Estrogen receptor β1 activation accelerates resistance to epidermal growth factor receptor-tyrosine kinase inhibitors in non-small cell lung cancer
Shengling Fu(Tongji Hospital), Qian Chu(Tongji Hospital)
Cited by 14
Related Papers
Notch signaling pathway: architecture, disease, and therapeutics
|Signal Transduction and Targeted Therapy|2022|1k
Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors
|Journal of Hematology & Oncology|2022|178
DACH1 inhibits cyclin D1 expression, cellular proliferation and tumor growth of renal cancer cells
|Journal of Hematology & Oncology|2014|71
Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutations
|The Innovation|2024|12